logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hongxing Pan

Jiangsu Provincial Center for Disease Control and Prevention
H指数:24
被引数:4,147

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The efficacy, immunogenicity and safety of the LZ901 vaccine for herpes zoster virus in adults 40 years of age or older: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

LZ901疫苗在40岁及以上成人中针对带状疱疹病毒的疗效、免疫原性和安全性：一项多中心、随机、双盲、安慰剂对照的III期临床试验

Nature Communications
IF15.7
2026-08-070
OA
Pengfei Jin; Yaru Quan; Xuefeng Gao; Mingwei Wei; Xiang Cao; Hongxing Pan; Heng Shen; Lei Zhao; Qing Xu; Zhao Wang; Xiaodong Liu; Jinmei Xu; Kangwei Xu; Wenyan Wan; Yeqing Tong; Li Zhang; Songtao Xu; Jingxin Li
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial

大肠杆菌生产九价人乳头瘤病毒疫苗的有效性、安全性和免疫原性：一项多中心、双盲、随机、对照、Ⅲ期试验

Lancet Infectious Diseases
IF31
2026-06-300
PRE
Hong-Xing Pan; Zhao-Feng Bi; Yu-Lin Jing; Shang-Ying Hu; Li Zhang; Kong-Xin Zhu; Kai Chu; Ying Hong; Shu-Fang Chang; Qin-Jing Pan; Xun Zhang; Jin-Bo Xu; Jie Tang; Dong-Ya Yuan; Hui Jiang; Chao Du; Guang Sun; Guo-Hua Zhong; Qi Chen; Li-Hui Wei
Post-marketing Safety Surveillance of 23-Valent Pneumococcal Polysaccharide Vaccine Administered Alone and Concomitantly with Influenza Vaccine in Individuals Aged 2 Years and Older in China

中国2岁及以上人群单独及与流感疫苗同时接种23价肺炎球菌多糖疫苗的上市后安全性监测

Infectious Diseases and Therapy
IF5.3
2026-02-230
OAAI
Yun-feng Shi; Lin-hang Ju; Kang-ning Wang; Yu Pan; Yu-ying Zou; Xi Lu; Ling Tuo; Wen-tao Zou; Ming-wei Wei; Yan-wei Zhao; Hong-xing Pan
Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles–Mumps–Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial

Sabin株灭活脊髓灰质炎病毒疫苗加强剂次分别或同时与灭活甲型肝炎疫苗或麻疹-流行性腮腺炎-风疹联合减毒活疫苗接种时的免疫原性和安全性：一项开放标签、随机、对照、IV期临床试验

Vaccines 2025, Vol. 13, Page 1087
IF0
2025-10-230
OAAI
Jialei Hu; Weixiao Han; Kai Chu; Hengzhen Zhang; Ling Tuo; Xiaoqian Duan; Jun Li; Fang Yuan; Chunfang Luan; Hongxing Pan; Peng Jiao
Immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18–26 years: three-year follow-up data from a randomised clinical trial

中国18～26岁女性中由大肠杆菌生产的九价人乳头瘤病毒疫苗与Gardasil9的免疫原性比较：一项随机临床试验的三年随访数据

lancet regional health western pacific
IF0
2025-08-270
PREAI
Guo-Hua Zhong; Zhao-Feng Bi; Kai Chu; Li Zhang; Lu Chen; Kong-Xin Zhu; Jia-Li Quan; Chu Nie; Qi Chen; Ling-Xian Qiu; Jin-Bo Xu; Jia-Xue Li; Ming-Lei Zhang; Sheng Liu; Ling-Ling Nie; Kun Li; Ying-Ying Su; Shou-Jie Huang; Qiu-Fen Zhang; Wei-Jin Huang; Hong-Xing Pan; Ting Wu; Jun Zhang; Ning-Shao Xia
Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults ≥50 years of age: a randomised, active-controlled, non-inferiority trial

带状疱疹重组gE-Fc融合蛋白亚单位疫苗在≥50岁成人中的免疫原性和安全性：一项随机、活性对照、非劣效性试验

Nature Communications
IF15.7
2025-08-150
OAAI
Peng-Fei Jin; Ya-Ru Quan; Shi-Xin Xiu; Xian-Min Jiang; Hong-Xing Pan; Yuan Shen; Xu-Wen Wang; Jian Kong; Wen-Juan Wang; Xiang Cao; Kang-Wei Xu; Min Yang; Kun Yang; Wen-Yan Wan; Kai-Qin Wang; Li Chen; Ai-Hua Yao; Yu-Peng Xue; Na Wan; Ming Xu; Shi-Yao Tao; Ling Peng; Fang-Rong Yan; Chang-Gui Li; Jing-Xin Li
Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial

COVID-19 DNA疫苗加强针在18岁及以上健康成人中的免疫原性和安全性：一项单中心、随机、观察者盲法、安慰剂对照的II期试验

BMC INFECTIOUS DISEASES
IF3
2025-05-250
OA
Yao, Aihua; Jia, Siyue; Cheng, Xin; Pan, Hongxing; Wang, Zhijian; Yang, Haitao; Xia, Yu; Xu, Jianfang; Huai, Xuefen; Leng, Danjing; Xu, Ming; Wang, Jiarong; Zhao, Gan; Wang, Bin; Li, Jingxin
Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China

雾化或肌肉注射腺病毒5型载体COVID-19疫苗加强针的有效性：一项在中国进行的多中心、部分随机、平台试验

NATURE COMMUNICATIONS
IF15.7
2025-03-260
OA
Jia, Siyue; Liu, Yuanbao; He, Qian; Pan, Hongxing; Liang, Zhenglun; Zhou, Juan; Pan, Yingzi; Liu, Sheng; Wu, Jingjing; Yang, Kun; Zhang, Xuanxuan; Zhao, Yang; Li, Simin; Zhang, Lei; Chen, Li; Yao, Aihua; Lu, Mengyi; Zhu, Fengcai; Li, Jingxin
Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China

水痘减毒活疫苗在13至55岁健康受试者中的免疫原性和安全性: 中国的双盲，随机，主动对照III期临床试验

EXPERT REVIEW OF VACCINES
IF4.8
2025-02-070
OA
Zhang, Yang; Wang, Shiyuan; Li, Guifan; Shi, Jinhui; Chang, Xianyun; Zhang, Hao; Zhu, Fengcai; Li, Jingxin; Pan, Hongxing; Sun, Jinfang
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial

COVID-19 DNA疫苗在健康成人和老年人中的免疫原性和安全性: 一项随机，观察者盲，安慰剂对照的2期试验

HUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
2025-01-260
OAAI
Jia, Siyue; Shao, Chengwei; Cheng, Xin; Pan, Hongxing; Wang, Zhijian; Xia, Yu; Xu, Jianfang; Huai, Xuefen; Leng, Danjing; Wang, Jiarong; Zhao, Gan; Wang, Bin; Li, Jingxin; Zhu, Fengcai
Immunogenicity and safety of an ORF7-deficient skin- attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2atrial

水痘ORF7-deficient皮肤减毒和神经减毒活疫苗的免疫原性和安全性: 随机，双盲，对照，2期心房

LANCET INFECTIOUS DISEASES
IF31
2024-08-011
PRE
Pan, Hong-Xing; Qiu, Ling-Xian; Liang, Qi; Chen, Zhen; Zhang, Ming-Lei; Liu, Sheng; Zhong, Guo-Hua; Zhu, Kong-Xin; Liao, Meng-Jun; Hu, Jia-Lei; Li, Jia-Xue; Xu, Jin-Bo; Fan, Yong; Huang, Yue; Su, Ying-Ying; Huang, Shou-Jie; Wang, Wei; Han, Jin-Le; Jia, Ji-Zong; Zhu, Hua; Cheng, Tong; Ye, Xiang-Zhong; Li, Chang-Gui; Wu, Ting; Zhu, Feng-Cai; Zhang, Jun; Xia, Ning-Shao
Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study
EMERGING MICROBES & INFECTIONS
IF7.5
2024-04-281
OAAI
Jia, Siyue; Yin, Zundong; Pan, Hongxing; Wang, Fuzhen; Liu, Xiaoqiang; Wang, Qing; Zhang, Li; Tang, Jihai; Yang, Hao; Du, Jiangbo; Wang, Zhiguo; Jin, Pengfei; Peng, Zhihang; Tang, Rong; Kang, Guodong; Wang, Xuewen; Li, Simin; Wang, Weixiao; Li, Jingxin; Shen, Hongbing; Zhu, Fengcai
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial
LANCET INFECTIOUS DISEASES
IF31
2023-11-0111
PRE
Zhu, Feng-Cai; Zhong, Guo-Hua; Huang, Wei-Jin; Chu, Kai; Zhang, Li; Bi, Zhao-Feng; Zhu, Kong-Xin; Chen, Qi; Zheng, Ting-Quan; Zhang, Ming-Lei; Liu, Sheng; Xu, Jin-Bo; Pan, Hong-Xing; Sun, Guang; Zheng, Feng-Zhu; Zhang, Qiu-Fen; Yi, Xiu-Mei; Zhuang, Si-Jie; Huang, Shou-Jie; Pan, Hui-Rong; Su, Ying-Ying; Wu, Ting; Zhang, Jun; Xia, Ning-Shao
Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3-8 Years

一剂和两剂四价灭活流感疫苗 (IIV4) 在未接种疫苗的儿童中的免疫原性和安全性，以及一剂IIV4在3-8岁的接种疫苗的儿童中的免疫原性和安全性

VACCINES
IF3.4
2023-10-122
OAAI
Shi, Yunfeng; Yang, Wanqi; Li, Xiaoyu; Chu, Kai; Wang, Jianfeng; Tang, Rong; Xu, Li; Li, Lanshu; Hu, Yuansheng; Zhao, Chenyan; Pan, Hongxing
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial
SCIENCE BULLETIN
IF21.1
2023-10-016
OAAI
Hu, Yue-Mei; Bi, Zhao-Feng; Zheng, Ya; Zhang, Li; Zheng, Feng-Zhu; Chu, Kai; Li, Ya-Fei; Chen, Qi; Quan, Jia-Li; Hu, Xiao-Wen; Huang, Xing-Cheng; Zhu, Kong-Xin; Wang-Jiang, Ya-Hui; Jiang, Han -Min; Zang, Xia; Liu, Dong-Lin; Yang, Chang -Lin; Pan, Hong-Xing; Zhang, Qiu-Fen; Su, Ying-Ying; Huang, Shou-Jie; Sun, Guang; Huang, Wei-Jin; Huang, Yue; Wu, Ting; Zhang, Jun; Xia, Ning-Shao

研究方向

暂未获取到该数据
F
Fengcai Zhu
H 指数:58论文数:390被引数:1.5万
李
李靖欣
H 指数:38论文数:203被引数:7,047
K
Kai Chu
H 指数:24论文数:133被引数:4,052
X
Xiling Guo
H 指数:31论文数:122被引数:3,553
S
Siyue Jia
H 指数:6论文数:41被引数:296
P
Pengfei Jin
H 指数:12论文数:70被引数:779
Y
Yunfeng Shi
H 指数:41论文数:235被引数:8,578
张军 封面图
张军
H 指数:71论文数:1,009被引数:2.4万
T
Ting Wu
H 指数:36论文数:238被引数:5,183
W
Weijin Huang
H 指数:50论文数:396被引数:2.0万